Pharmaceutical Products and CMO Market Report

Global and Region Pharmaceutical Products and CMO Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 29, 2022
  • PAGES：198
  • REPORT CODE：GMM891424
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Pharmaceutical Products and CMO market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Pharmaceutical Products and CMOmarket, defines the market attractiveness level of Pharmaceutical Products and CMO market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Pharmaceutical Products and CMO industry, describes the types of Pharmaceutical Products and CMO market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pharmaceutical Products and CMO market and the development prospects and opportunities of Pharmaceutical Products and CMO industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pharmaceutical Products and CMO market in Chapter 13.

    By Player:

    • Dishman

    • Recipharm

    • Jubilant

    • Aesica

    • Nipro Corp

    • NextPharma Technologies

    • Fareva Holding

    • Famar

    • DPx

    • Mylan (DPT Laboratories)

    • AbbVie

    • Catalent

    • Aenova

    • Piramal Healthcare

    • Boehringer Ingelheim

    • Lonza

    • Sopharma

    • Vetter

    By Type:

    • Active Pharmaceutical Ingredient (API)

    • Finished Dosage Form (FDF)

    • Pharmaceutical Packaging

    By End-User:

    • Specialty/Midsize

    • Generics

    • Big Pharma

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Pharmaceutical Products and CMO Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Pharmaceutical Products and CMO Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Pharmaceutical Products and CMO Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Pharmaceutical Products and CMO Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Pharmaceutical Products and CMO Market Analysis and Outlook to 2022

    • 7.1 Global Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.2 United States Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.3 Europe Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.4 China Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.5 Japan Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.6 India Pharmaceutical Products and CMO Consumption (2017-2022)

    • 7.7 South Korea Pharmaceutical Products and CMO Consumption (2017-2022)

    8 Region and Country-wise Pharmaceutical Products and CMO Market Analysis and Outlook to 2028

    • 8.1 Global Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.2 United States Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.3 Europe Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.4 China Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.5 Japan Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.6 India Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    • 8.7 South Korea Pharmaceutical Products and CMO Consumption Forecast (2022-2028)

    9 Global Pharmaceutical Products and CMO Market Outlook by Types and Applications to 2022

    • 9.1 Global Pharmaceutical Products and CMO Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Finished Dosage Form (FDF) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Pharmaceutical Packaging Consumption and Growth Rate (2017-2022)

    • 9.2 Global Pharmaceutical Products and CMO Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Specialty/Midsize Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Generics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Big Pharma Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Pharmaceutical Products and CMO Market Outlook by Types and Applications to 2028

    • 10.1 Global Pharmaceutical Products and CMO Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Finished Dosage Form (FDF) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Pharmaceutical Packaging Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Pharmaceutical Products and CMO Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Generics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Pharmaceutical Products and CMO Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Pharmaceutical Products and CMO Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Pharmaceutical Products and CMO Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Pharmaceutical Products and CMO Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Pharmaceutical Products and CMO Market Competitive Analysis

    • 14.1 Dishman

      • 14.1.1 Dishman Company Details

      • 14.1.2 Dishman Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Dishman Pharmaceutical Products and CMO Product and Service

    • 14.2 Recipharm

      • 14.2.1 Recipharm Company Details

      • 14.2.2 Recipharm Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Recipharm Pharmaceutical Products and CMO Product and Service

    • 14.3 Jubilant

      • 14.3.1 Jubilant Company Details

      • 14.3.2 Jubilant Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Jubilant Pharmaceutical Products and CMO Product and Service

    • 14.4 Aesica

      • 14.4.1 Aesica Company Details

      • 14.4.2 Aesica Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Aesica Pharmaceutical Products and CMO Product and Service

    • 14.5 Nipro Corp

      • 14.5.1 Nipro Corp Company Details

      • 14.5.2 Nipro Corp Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Nipro Corp Pharmaceutical Products and CMO Product and Service

    • 14.6 NextPharma Technologies

      • 14.6.1 NextPharma Technologies Company Details

      • 14.6.2 NextPharma Technologies Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 NextPharma Technologies Pharmaceutical Products and CMO Product and Service

    • 14.7 Fareva Holding

      • 14.7.1 Fareva Holding Company Details

      • 14.7.2 Fareva Holding Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Fareva Holding Pharmaceutical Products and CMO Product and Service

    • 14.8 Famar

      • 14.8.1 Famar Company Details

      • 14.8.2 Famar Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Famar Pharmaceutical Products and CMO Product and Service

    • 14.9 DPx

      • 14.9.1 DPx Company Details

      • 14.9.2 DPx Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 DPx Pharmaceutical Products and CMO Product and Service

    • 14.10 Mylan (DPT Laboratories)

      • 14.10.1 Mylan (DPT Laboratories) Company Details

      • 14.10.2 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Service

    • 14.11 AbbVie

      • 14.11.1 AbbVie Company Details

      • 14.11.2 AbbVie Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 AbbVie Pharmaceutical Products and CMO Product and Service

    • 14.12 Catalent

      • 14.12.1 Catalent Company Details

      • 14.12.2 Catalent Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Catalent Pharmaceutical Products and CMO Product and Service

    • 14.13 Aenova

      • 14.13.1 Aenova Company Details

      • 14.13.2 Aenova Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Aenova Pharmaceutical Products and CMO Product and Service

    • 14.14 Piramal Healthcare

      • 14.14.1 Piramal Healthcare Company Details

      • 14.14.2 Piramal Healthcare Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Piramal Healthcare Pharmaceutical Products and CMO Product and Service

    • 14.15 Boehringer Ingelheim

      • 14.15.1 Boehringer Ingelheim Company Details

      • 14.15.2 Boehringer Ingelheim Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Boehringer Ingelheim Pharmaceutical Products and CMO Product and Service

    • 14.16 Lonza

      • 14.16.1 Lonza Company Details

      • 14.16.2 Lonza Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Lonza Pharmaceutical Products and CMO Product and Service

    • 14.17 Sopharma

      • 14.17.1 Sopharma Company Details

      • 14.17.2 Sopharma Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Sopharma Pharmaceutical Products and CMO Product and Service

    • 14.18 Vetter

      • 14.18.1 Vetter Company Details

      • 14.18.2 Vetter Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

      • 14.18.3 Vetter Pharmaceutical Products and CMO Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Pharmaceutical Products and CMO

    • Figure Pharmaceutical Products and CMO Picture

    • Table Global Pharmaceutical Products and CMO Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmaceutical Products and CMO Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Pharmaceutical Products and CMO Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Pharmaceutical Products and CMO Consumption by Country (2017-2022)

    • Figure United States Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Table Europe Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Figure China Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Figure Japan Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Figure India Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Figure South Korea Pharmaceutical Products and CMO Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Products and CMO Consumption Forecast by Country (2022-2028)

    • Figure United States Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Pharmaceutical Products and CMO Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption and Growth Rate (2017-2022)

    • Figure Global Finished Dosage Form (FDF) Consumption and Growth Rate (2017-2022)

    • Figure Global Pharmaceutical Packaging Consumption and Growth Rate (2017-2022)

    • Figure Global Specialty/Midsize Consumption and Growth Rate (2017-2022)

    • Figure Global Generics Consumption and Growth Rate (2017-2022)

    • Figure Global Big Pharma Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Active Pharmaceutical Ingredient (API) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Finished Dosage Form (FDF) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Pharmaceutical Packaging Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Specialty/Midsize Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Generics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Big Pharma Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Pharmaceutical Products and CMO Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Pharmaceutical Products and CMO Export by Region (Top 5 Countries) (2017-2028)

    • Table Dishman (Foundation Year, Company Profile and etc.)

    • Table Dishman Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Dishman Pharmaceutical Products and CMO Product and Service

    • Table Recipharm (Foundation Year, Company Profile and etc.)

    • Table Recipharm Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Recipharm Pharmaceutical Products and CMO Product and Service

    • Table Jubilant (Foundation Year, Company Profile and etc.)

    • Table Jubilant Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jubilant Pharmaceutical Products and CMO Product and Service

    • Table Aesica (Foundation Year, Company Profile and etc.)

    • Table Aesica Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aesica Pharmaceutical Products and CMO Product and Service

    • Table Nipro Corp (Foundation Year, Company Profile and etc.)

    • Table Nipro Corp Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Nipro Corp Pharmaceutical Products and CMO Product and Service

    • Table NextPharma Technologies (Foundation Year, Company Profile and etc.)

    • Table NextPharma Technologies Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table NextPharma Technologies Pharmaceutical Products and CMO Product and Service

    • Table Fareva Holding (Foundation Year, Company Profile and etc.)

    • Table Fareva Holding Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Fareva Holding Pharmaceutical Products and CMO Product and Service

    • Table Famar (Foundation Year, Company Profile and etc.)

    • Table Famar Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Famar Pharmaceutical Products and CMO Product and Service

    • Table DPx (Foundation Year, Company Profile and etc.)

    • Table DPx Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table DPx Pharmaceutical Products and CMO Product and Service

    • Table Mylan (DPT Laboratories) (Foundation Year, Company Profile and etc.)

    • Table Mylan (DPT Laboratories) Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Mylan (DPT Laboratories) Pharmaceutical Products and CMO Product and Service

    • Table AbbVie (Foundation Year, Company Profile and etc.)

    • Table AbbVie Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Pharmaceutical Products and CMO Product and Service

    • Table Catalent (Foundation Year, Company Profile and etc.)

    • Table Catalent Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Catalent Pharmaceutical Products and CMO Product and Service

    • Table Aenova (Foundation Year, Company Profile and etc.)

    • Table Aenova Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aenova Pharmaceutical Products and CMO Product and Service

    • Table Piramal Healthcare (Foundation Year, Company Profile and etc.)

    • Table Piramal Healthcare Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Piramal Healthcare Pharmaceutical Products and CMO Product and Service

    • Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)

    • Table Boehringer Ingelheim Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Pharmaceutical Products and CMO Product and Service

    • Table Lonza (Foundation Year, Company Profile and etc.)

    • Table Lonza Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lonza Pharmaceutical Products and CMO Product and Service

    • Table Sopharma (Foundation Year, Company Profile and etc.)

    • Table Sopharma Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sopharma Pharmaceutical Products and CMO Product and Service

    • Table Vetter (Foundation Year, Company Profile and etc.)

    • Table Vetter Pharmaceutical Products and CMO Sales, Price, Value and Gross Profit (2017-2022)

    • Table Vetter Pharmaceutical Products and CMO Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US